Solid Biosciences (SLDB) Operating Expenses (2017 - 2024)
Historic Operating Expenses for Solid Biosciences (SLDB) over the last 7 years, with Q4 2024 value amounting to $39.9 million.
- Solid Biosciences' Operating Expenses rose 7918.71% to $39.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $129.7 million, marking a year-over-year increase of 2443.69%. This contributed to the annual value of $129.7 million for FY2024, which is 2443.69% up from last year.
- Latest data reveals that Solid Biosciences reported Operating Expenses of $39.9 million as of Q4 2024, which was up 7918.71% from $35.2 million recorded in Q3 2024.
- In the past 5 years, Solid Biosciences' Operating Expenses registered a high of $39.9 million during Q4 2024, and its lowest value of $19.0 million during Q2 2020.
- Moreover, its 4-year median value for Operating Expenses was $26.9 million (2020), whereas its average is $27.3 million.
- As far as peak fluctuations go, Solid Biosciences' Operating Expenses tumbled by 3558.7% in 2023, and later skyrocketed by 7918.71% in 2024.
- Over the past 4 years, Solid Biosciences' Operating Expenses (Quarter) stood at $21.3 million in 2020, then soared by 61.92% to $34.6 million in 2022, then tumbled by 35.59% to $22.3 million in 2023, then soared by 79.19% to $39.9 million in 2024.
- Its last three reported values are $39.9 million in Q4 2024, $35.2 million for Q3 2024, and $27.8 million during Q2 2024.